The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Isoray
Research Funding - Bioprotect; Bristol-Myers Squibb/Celgene
Alkaline phosphatase (ALP) decline and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the REASSURE study.
 
Nicholas D. James
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; EUSA pharma; Janssen; pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Janssen Oncology; Merck; Pierre Fabre; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen; Sanofi
 
Daniel Heinrich
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Eisai
Research Funding - AstraZeneca (Inst); Eisai (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Elena Castro
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Janssen-Cilag; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; MSD Oncology; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst); SYNLAB (Inst)
Expert Testimony - Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Janssen; Roche
 
Saby George
Consulting or Advisory Role - AVEO; Bayer; Bristol-Myers Squibb; Corvus Pharmaceuticals; Eisai; EMD Serono; Exelixis; Merck; Pfizer; QED Therapeutics; Sanofi; Seattle Genetics/Astellas
Research Funding - Agensys (Inst); Aravive (Inst); Aveo (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Corvus Pharmaceuticals (Inst); Eisai (Inst); Exelixis (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst); Surface Oncology (Inst)
 
Daniel Y. Song
No Relationships to Disclose
 
Sabina Dizdarevic
Consulting or Advisory Role - Bayer; GE Healthcare
 
Sergio Baldari
No Relationships to Disclose
 
Markus Essler
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Ipsen
Travel, Accommodations, Expenses - Ipsen
 
Igle Jan de Jong
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Bayer
 
Secondo Lastoria
No Relationships to Disclose
 
Peter G. Hammerer
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen; Janssen
 
Jeffrey Meltzer
Employment - Bayer
Stock and Other Ownership Interests - Bayer; Bayer (I); Lilly; Lilly (I); Pfizer; Pfizer (I)
 
Per Sandstrom
Employment - Bayer
Stock and Other Ownership Interests - InVitae; Oasmia Pharmaceutical AB
 
Frank Verholen
Employment - Bayer
Travel, Accommodations, Expenses - Bayer
 
Bertrand F. Tombal
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Myovant Sciences; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen; Myovant Sciences; Pfizer/Astellas; Sanofi; Steba Biotech; Takeda
Speakers' Bureau - Amgen; Astellas Pharma; Astellas Pharma; Janssen
Research Funding - Ferring (Inst)
Expert Testimony - Steba Biotech
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Sanofi
 
Joe M. O'Sullivan
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Novartis; Sanofi
Speakers' Bureau - Bayer; Janssen; Novartis
Research Funding - Bayer (Inst)
 
A. Oliver Sartor
Stock and Other Ownership Interests - Abbvie; Cardinal Health; Clarity Pharmaceuticals; Clovis Oncology; GlaxoSmithKline; Lilly; Noria Therapeutics; PSMA Therapeutics; United Health Group
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bavarian Nordic; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Clarity Pharmaceuticals; Clovis Oncology; Constellation Pharmaceuticals; Dendreon; EMD Serono; Fusion Pharmaceuticals; Isotopen Technologien; Janssen; Myovant Sciences; Myriad Genetics; Noria Therapeutics; Novartis; Noxopharm; Pfizer; Point Biopharma; Progenics; Sanofi; Telix Pharmaceuticals; TeneoBio; Theragnostics
Research Funding - Advanced Accelerator Applications (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Endocyte (Inst); InVitae (Inst); Janssen; Lantheus Medical Imaging (Inst); Merck (Inst); Progenics; Sanofi (Inst); SOTIO
Patents, Royalties, Other Intellectual Property - Koochekpour, Sartor AO, inventors. Saposin C and receptors as targets for treatment of benign and malignant disorders. US patent awarded January 23, 2007 (patent no. 7,166,691).
Expert Testimony - Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Johnson & Johnson; Progenics; Sanofi